Allergic diseases diagnosis and treatment

2024 Activity Indicators

  • 3 national public competitive projects led: ISCIII
  • 5 private projects led
  • 15 clinical studies led
  • 19 publications
  • IF: 105.70
  • Q1 publications: 16 (84%)
  • D1 publications: 2 (11%)
  • 1 award for quality in care and research in Allergology
  • Evaluators from medical agencies and societies: 4 researchers
  • Members of editorial comittees: 2 researchers
  • 7 visitors and 10.7 months of stay:
    • Polytechnic University of Madrid
    • Sant Joan de Deu Hospital
    • University Hospital of Santiago de Chile (Chile)
    • Jimenez Diaz Foundation
    • Princess University Hospital
    • Txagorrithu Hospital, Vitoria
    • Elche Hospital

Milestones

  1. Certification as a Center of Excellence in Allergology by the World Allergy Organization.
  2. Certification as a Multidisciplinary Unit of Excellence in Severe Asthma of High Complexity by SEPAR and SEAIC.
  3. Participation as a research group in the competitive public project (ISCIII) - Fortalece (FORT23/00046): Innovative Therapies for Personalized and Precision Medicine in Health Challenges.
  4. Inclusion of the research project on allergy to beta-lactam antibiotic drugs (PROA-ALERGIA) in the PROA of infectious diseases.
  5. Publication of the validation of the environmental exposure chamber for the study of respiratory allergy due to grass pollen.

Bibliometrics

  Articles Accum. FI Mean FI Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % in D1
2020 17 48.97 2.88 8 47 1 6
2021 17 93.25 5.49 15 88 2 12
2022 12 88.70 9.86 8 66,67 1 8,33
2023 36 237.52 7.20 32 89 5 14
2024 19 105.70 5.87 18 95 2 11
  101 574.14 6.26 81 80 11 11

* Only original articles, editorials, guidelines and reviews

Networks and alliances

  • Piel en Red
  • Comité de vacunas de FACME
  • AEMPS
  • Imperial College London
  • Universidad San Pablo CEU
  • Universidad Politécnica de Madrid, Escuela de Telecomunicaciones
  • Red Española de Mastocitosis